Status:
COMPLETED
An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Adult Hepatocellular Carcinoma
Stage III Hepatocellular Carcinoma AJCC v8
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies how well an investigational scan (magnetic resonance elastography \[MRE\]) works with standard imaging (magnetic resonance imaging \[MRI\]) in detecting response to treatment in pat...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the ability of magnetic resonance (MR) elastography (MRE) to detect changes in hepatocellular carcinoma (HCC) between baseline and after initial 6 weeks of treatment...
Eligibility Criteria
Inclusion
- Liver cancer.
- Available tumor and liver parenchyma tissue (biopsy-proven HCC).
- No contraindications to MRI (such implanted ferromagnetic or pump devices, metallic fragments in eye), as indicated on our departmental MRI screening form.
- Able to undergo informed consent.
- Not pregnant.
Exclusion
- Contraindication to MRI (including cardiac pacemaker; ferromagnetic foreign objects in the patient; metallic eye fragments; claustrophobia).
- Inability to comply with study and/or follow-up procedures.
Key Trial Info
Start Date :
June 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 13 2025
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04022746
Start Date
June 11 2019
End Date
February 13 2025
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030